A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer

Published:2001-08-01 Issue:2 Volume:48 Page:109-114
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Olver Ian,Davy Margaret,Lüftner Diana,Park So-Hyang,Egorin Merrill,Ellis Andrew,Webster Lorraine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800000263.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance test;Cancer Chemotherapy and Pharmacology;2011-05-28

2. A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship;Cancer Treatment Reviews;2007-12

3. Labelled compounds of interest as antitumour agents - VIII. Synthesis of2H-isotopomers of pentamethylmelamine and of a potential prodrug thereof;Journal of Labelled Compounds and Radiopharmaceuticals;2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP